Physician Dialysis of Miami, Florida increased its investment in technology to replace generalized ESA protocols and better manage Hgb Cycling.
Physicians software systems announced that Physicians Dialysis was more than doubling its investment in Individualized Anemia Management - PhySoft AMS™.
Physicians Dialysis began using PhySoft AMS™ early in 207 to better manage patient anemia and growing ESA administration expenses. It implemented the decision support software in its six dialysis facilities, which treat 325 patients in Florida and Georgia. In September, Physicians Dialysis expanded its utilization of the anemia management system to license the decision support tool for its seven recently acquired clinics in New Jersey and Texas.
Physicians Dialysis is a physician-owned and directed dialysis provider, which has operated in the southeast U.S. for nearly 30 years. With their recent acquisition of seven additional facilities, they have more than doubled their patient population to 750 patients.
Individualized anemia management from Physician Software Systems provides the logical next step to better control Hgb Cycling that more than 90% of ESRD patients experience. The elimination of dosing protocol dependence will also help Physicians Dialysis control the drug expense and waste associated with protocol-based dosing adjustments. Individualized anemia management is capable of delivering a significant reduction in ESA expense, while stabilizing patient Hgb levels.
About PhySoft AMS™
The Physician Software Systems Anemia Management System™ was created in cooperation with Mayo Clinic. Mayo Clinic's top-rated Nephrology department developed the underlying technology to better manage hemoglobin levels across its dialysis network. The system analyzes patient dosing history and Hgb labs to model each patient's response to ESAs. PhySoft AMS™ then recommends a number of optimum dosing regimens for each obtainable Hgb target. The physician then chooses the appropriate Hgb target for his or her patient. The system assists Mayo Clinic and other organizations to provide treatment based upon each patient's unique physiology - better managing Hgb Cycling, while reducing costs.